Epstein-Barr Virus (EBV) and Chronic Immune Activation Part 3
Our first two episodes on EBV were about the nature of the virus, how it leverages the immune system into developing autoimmunity. In this week’s third installment, we roll up our sleeves and take a look at building a support structure for the patient and what outcomes should look like.
- View the resources for Epstein-Barr Virus (EBV) and Chronic Immune Activation Part 3
More in This Series
-
Epstein-Barr Virus (EBV) and Chronic Immune Activation
Join Dr. Watts for a walkthrough of one of the sneakiest, most pervasive underlying mechanisms of autoimmunity—EBV! Over 90% of adults worldwide have been infected with Epstein-Barr Virus (EBV), making it one of the most prevalent human viral infections. He’ll lay out the medical literature, assessment models, and protocol development. View the resources for Epstein-Barr ... -
Epstein-Barr Virus (EBV) and Chronic Immune Activation Part 2
This week, get ready for the next step in our EBV sequence of webinars. In this 2nd episode, we’ll take a look at EBV’s ability to expand its impact within the immune system to leverage itself into new and different conditions. View the resources for Epstein-Barr Virus (EBV) and Chronic Immune Activation Part 2

